Group 1 - The medical device ETF (562600) opened lower but closed up by 1.25%, with leading stocks such as Hotspring Bio rising by 11.40% and Jimin Health and Zhend Medical hitting a strong limit up of 10% [1] - The National Medical Products Administration (NMPA) has focused on key areas such as medical robots, high-end medical imaging, AI medical devices, and new biological materials, approving 52 innovative products this year, totaling 367 approved innovative products to date [1] - Recent high-level discussions emphasized principles like "anti-involution" and "optimizing centralized procurement without solely focusing on low prices," indicating a clear signal for policy shifts supporting the innovative medical device industry [1] Group 2 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device sector, tracking the CSI All Share Medical Device Index, which includes 100 representative listed companies in core medical fields [2] - The medical device sector accounts for a significant 89.34% of the index, indicating a concentrated focus on capturing the development dividends in this field [2] - As of the first quarter of 2025, the top ten holdings in the medical device ETF (562600) include Mindray Medical and United Imaging, which together account for 22.3% of the ETF [2]